Abstract
Growing epidemiological evidence shows that psychological stress is strongly associated with pathogenesis in modern society a correlational finding). Its effects on CNS are highly age- and cell-type specific. This review outlines how stress regulates mitophagy and dynamically disrupt CNS homeostasis across different life stages, including fetal development, adolescence, and aging, as well as across distinct cell types such as neurons, astrocytes, and microglia. These alterations ultimately increase susceptibility to neurodevelopmental and neurodegenerative disorders.): We propose an integrated “cell–age–stress” framework (Hypothesis 1) that highlights the bidirectional crosstalk between stress-induced mitochondrial damage and nuclear epigenetic reprogramming. We also present a “lifespan intervention hypothesis” (Hypothesis 2) and discuss precision fine-tuning strategies targeted to specific life stages and cell types, offering new directions for neuroprotective therapies.
1 Introduction
Psychological stress has become a pervasive challenge in modern society, disrupting neurophysiological homeostasis through multiple signaling pathways (; ). Neuroimaging studies have demonstrated that maternal and early-life stress induce structural and functional alterations in several brain regions, including the temporal lobe, frontal lobe, and amygdala (; Van den Bergh et al., 2020). These adverse effects can occur throughout the lifespan. Prenatal maternal stress, social adversity, abuse, emotional neglect, malnutrition, and exposure to violence have all been associated with impaired neural development (Sanguino-Gómez and Krugers, 2024). In addition to its links to altered brain development, psychological stress has been correlated with accelerated cellular senescence (), and is associated with the aggravation of age-related neurodegenerative processes. Consequently, chronic stress has been implicated in the pathogenesis of various psychiatric and neurological disorders, including psychiatric disorders such as depression, Generalized Anxiety Disorder (GAD), Obsessive-Compulsive Disorder (OCD), Post-Traumatic Stress Disorder (PTSD), and neurodegenerative diseases such as Alzheimer’s Disease (AD) and Parkinson’s Disease (PD) (; ; ).
Mitophagy is a specialized form of autophagy that selectively removes damaged or dysfunctional mitochondria. By doing so, it preserves organelle integrity and supports the generation of new mitochondria. Dysregulated mitophagy is implicated in numerous diseases. Mounting evidence shows that mitophagy is regulated in a highly cell-specific manner, especially in neurons. Neuronal mitophagy directly maintains circuit integrity and modulates vulnerability to neurodegeneration (; Zhang et al., 2021). In the CNS, mitophagy is tightly controlled and dynamically balanced. Moderate mitophagy effectively clears stress-induced mitochondrial damage and sustains homeostasis in neurons and glia (; Zhang et al., 2021; Picca et al., 2023). In contrast, insufficient mitophagy leads to the buildup of damaged mitochondria, elevated Reactive Oxygen Species (ROS) production, reduced Adenosine Triphosphate (ATP) synthesis, mitochondrial dysfunction, and eventual apoptosis (Su et al., 2023).
Stress initiates mitophagy via two main pathways: the ubiquitin-dependent PTEN-induced Kinase 1 (PINK1)-an E3 ubiquitin ligase (Parkin) pathway and the ubiquitin-independent pathway mediated by BCL2 interacting protein 3 (BNIP3), NIP3-like protein X (NIX), and FUN14 domain containing 1 (FUNDC1). Under stress, mitochondrial import through the Translocase of the Outer Mitochondrial membrane (TOM)/Translocase of the Inner Mitochondrial membrane (TIM) complex is impaired, causing PINK1 to accumulate and activate on the outer mitochondrial membrane (; ; ). Parkin subsequently polyubiquitinates proteins on the outer mitochondrial membrane (). These ubiquitin chains are recognized by autophagy receptors, including Sequestosome one (p62/SQSTM1), Optineurin (OPTN), Nuclear Dot Protein 52 (NDP52), Tax1-binding protein 1 (TAX1BP1). Through their microtubule-associated protein 1 Light Chain 3 (LC3) interacting regions (LIR) (Panigrahi et al., 2020; ; Nguyen et al., 2023), these receptors tether damaged mitochondria to the phagophore and facilitate autophagosome formation. The phagophore engulfs damaged mitochondria to form a double-membrane autophagosome, which fuses with lysosomes to form an autolysosome. Within the autolysosome, hydrolases degrade mitochondrial components, completing the removal of damaged organelles (). The BNIP3/NIX/FUNDC1 pathway functions in a ubiquitin-independent manner. These outer mitochondrial membrane proteins directly interact with LC3, thereby facilitating the recruitment of mitochondria to the phagophore (; Wu et al., 2021).
Psychological stress is a major disruptor of mitophagic homeostasis. Stress signaling—particularly via Hypothalamic-Pituitary-Adrenal (HPA) axis activation—directly impairs mitochondrial function and epigenetically regulates the expression of mitophagy-related genes, altering pathway efficiency (; Sanacora et al., 2022; ). In addition, altered methylation and hydroxymethylation of mitochondrial DNA (mtDNA) are closely linked to disease-associated mitochondrial dysfunction and may retrogradely modify nuclear epigenetic states (Stoccoro and Coppedè, 2021; Mostafavi Abdolmaleky and Zhou, 2024). Together, these observations support a unifying hypothesis: in the nervous system, mitophagy acts not only as a housekeeping process for organelle quality control but also as a dynamic regulator of stress adaptation.
In this review, we outline the life-cycle progression of stress-induced mitophagy. During the fetal period, maternal stress programs mitophagy through epigenetic modifications to drive compensatory adaptation (; ). In adolescence, the combination of heightened brain plasticity and ongoing stress can destabilize this balance. Mitochondria-to-nucleus metabolic-epigenetic crosstalk then becomes maladaptive, promoting mitochondrial dysfunction and increasing susceptibility to neuropsychiatric disorders (; West et al., 2015; ; Zhou et al., 2024). In late life, cellular aging and cumulative stress drive systemic failure of mitophagy, sharply elevating the risk of neurodegenerative diseases (Redmann et al., 2016; ; ). Therefore, understanding how stress reshapes mitophagy across the lifespan is critical for deciphering age-dependent vulnerability to neuropsychiatric and neurodegenerative conditions.
2 Psychological stress converges on mitochondria
2.1 Direct effects of excess glucocorticoids on mitochondrial oxidative stress and dynamics
Stress activates the HPA axis and triggers excess Glucocorticoid (GC) synthesis and release (O’Connor et al., 2021). In CNS, adverse prenatal environments also elevate GCs levels (; ), reduce Glucocorticoid Receptor (GR) and Mineralocorticoid Receptor (MR) expression, and suppress Brain-Derived Neurotrophic Factor (BDNF) transcription, synapse formation, and BDNF-dependent dendritic growth (). A study of 187 abused children aged 7–17 years revealed widespread HPA axis dysfunction characterized by increased daily cortisol output (Marques-Feixa et al., 2023). Consistently, chronic high stress and elevated cortisol in late childhood or adolescence positively correlate with an increased risk of psychosis () (an epidemiological correlation). However, it is important to note that these clinical observations primarily reflect correlation rather than direct causation. In older adults, impaired neuroendocrine–immune crosstalk is associated with heightened vulnerability to emotional stress, and high cortisol levels are linked to cognitive decline and dementia In older adults, impaired neuroendocrine–immune crosstalk heightens vulnerability to emotional stress, and high cortisol levels are linked to cognitive decline and dementia (Muntsant and Giménez-Llort, 2022).
GCs regulate multiple energy-consuming processes, including mitochondrial energy metabolism. GCs enhance their own anti-inflammatory effects by promoting Tricarboxylic Acid (TCA) cycle–mediated mitochondrial metabolic reprogramming (). The effects of GCs on mitochondria are biphasic: short-term exposure supports mitochondrial biogenesis and boosts respiratory chain enzyme activity, whereas prolonged exposure impairs respiratory chain function, reduces ATP production, increases ROS generation, and distorts mitochondrial structure (). In osteoblast death, GCs trigger excessive ROS and disrupt mitochondrial homeostasis (), suggesting a conserved mechanism in CNS cells. ROS selectively damages telomeres, inhibits telomerase, and activates the p53 pathway, which reduces mitochondrial biogenesis and represses peroxisome proliferator-activated receptor-γ coactivator-1α (PGC-1α) promoter activity (; ; ). As a master regulator of mitochondrial biogenesis and oxidative metabolism, PGC-1α balances mitophagy and mitochondrial synthesis while limiting ROS accumulation. Notably, PGC-1α inhibition reduces NIX-dependent mitophagy, causes mitochondrial accumulation, and induces synaptic deficits in hippocampal neurons, SH-SY5Y cells, and ICR mice, marked by reduced synaptic density and impaired vesicle recycling (). Therefore, we hypothesize that PGC-1α may be a critical molecular mediator through which GCs induce mitochondrial damage.
At the ionic level, studies have shown that ROS (e.g., hydrogen peroxide) regulate the trafficking of AMPA subtype of synaptic glutamate receptors (AMPARs) by modulating activity-dependent calcium signaling (). When neurons are excited, Ca2+ rapidly enters mitochondria, followed by an increase in ROS production. This ROS signaling leads to the downregulation of excitatory synaptic channel expression, indicating that mitochondrial Ca2+ and ROS act synergistically to regulate synaptic excitability, positioning mitochondrial membrane potential (MMP) at the core of the regulatory network (). MMP is crucial for the recruitment of Parkin in mitophagy. Low membrane potential leads to the selective recruitment of Parkin to mitochondria, thereby triggering further mitophagy. (Narendra et al., 2010). Based on this, we propose the hypothesis that ROS accumulation induced by GCs may affect MMP by increasing mitochondrial Ca2+ influx, thereby influencing mitophagy.
2.2 Stress-induced epigenetic modifications imprint mitochondrial function
Growing evidence indicates that maternal pre-conception stress is associated with excess GC release and mitochondrial oxidative stress, which correlates with intergenerational epigenetic reprogramming and persistent neurodevelopmental deficits in offspring (; ). Building on these correlational findings, we speculatively hypothesize that such epigenetic marks—potentially mediated by dysregulated mitophagy—might participate in transgenerational feedback loops. However, whether these stress-induced epigenetic signatures are truly heritable across multiple generations without decaying remains a speculative hypothesis requiring rigorous transgenerational animal studies. In offspring of Holocaust survivors, maternal prenatal stress alters HPA axis sensitivity through DNA methylation of the GR gene (). Parallel findings in rodent models show that poor maternal care induces hypermethylation of CpG islands in the GR promoter region (McEwen et al., 2016). Early-life trauma, including physical, sexual, or emotional abuse and neglect, is associated with sustained HPA axis abnormalities, including impaired GCs-mediated negative feedback and heightened cortisol reactivity in adulthood (Nikkheslat et al., 2020). Childhood maltreatment is strongly correlated with hypermethylation of exon 1F of the GR gene (NR3C1) in the hippocampus, reducing GR expression and amplifying stress-related depression- and anxiety-like responses (). In stressed myocardium, activated NR3C1 disrupts calcium homeostasis and mitochondrial quality control by inhibiting glomulin (GLMN) (), in clear cell renal cell carcinoma, NR3C1 induces mitophagy via the activating transcription factor 6 (ATF6)–PINK1/BNIP3 pathway (Yan et al., 2023). Although these findings have not yet been validated in CNS disorders, we propose the following hypothesis: NR3C1 methylation contributes to CNS disease pathogenesis through the downstream regulation of mitochondrial function and mitophagy. Further causal studies using cell-type-specific knockouts in neurons and glial cells are required to test this hypothesis.
The epigenetic regulator methyl-CpG-binding protein 2 (MECP2) mediates experience-dependent programming of HPA axis genes, including Corticotropin-Releasing Hormone (CRH) and Arginine Vasopressin (AVP). Hemizygous female MECP2 mice show anxiety-like behavior and reduced paraventricular nucleus activation, confirming MECP2’s role in HPA reprogramming (). This effect likely involves CpG island methylation driven by interactions between MECP2 and RNA polymerase II (Pol II) (). CRISPR-Cas9–edited MECP2 mutants show impaired mitophagy due to dysregulated BNIP3L expression (Zhou et al., 2026). In stroke models, lactylated MECP2 disrupts mitochondrial respiration, metabolic signaling, and neuroinflammation (Zhang et al., 2026). As a stress-responsive epigenetic regulator, MECP2 likely mediates stress effects by transcriptionally controlling downstream targets, including mitophagy-related genes.
In most neurodevelopmental syndromes, differentially methylated positions (DMPs) and regions (DMRs) are enriched in gene promoters and CpG islands, especially for genes involved in neurogenesis, synaptic signaling, and transmission (). In AD, aberrant methylation of Amyloid Precursor Protein (APP), Presenilin 1 (PSEN1), Beta-site APP Cleaving Enzyme 1 (BACE1), Microtubule-Associated Protein Tau (MAPT), and Apolipoprotein E (APOE) coincides with histone deacetylation–dependent synaptic and memory impairment (). APOE is a major genetic risk factor for AD and regulates histone acetylation in neurons. APOE enriches histone H3 lysine 27 acetylation (H3K27ac) at immediate-early gene promoters to support memory consolidation (; ). APOE4 causes lysosomal lipid accumulation and blocked autophagic flux (; ), possibly through altered histone acetylation. In neurodegenerative diseases, mtDNA methylation and hydroxymethylation are altered, most prominently in the mitochondrial D-loop region, consistent with disease-related mitochondrial dysfunction (Stoccoro and Coppedè, 2021).
2.3 Stress leaves an initial molecular imprint on mitochondria via epigenetic modification
As illustrated in Figure 1, chronic psychological stress triggers excess GCs release, directly impairing mitochondrial function, increasing ROS accumulation, disrupting energy metabolism, and unbalancing mitochondrial dynamics, this process downregulates PGC-1α. At the ionic level, the accumulation of ROS leads to mitochondrial Ca2+ influx and changes in mitochondrial membrane potential (MMP), which may affect mitophagy (NIX, Parkin) and further impact the CNS. At a deeper level, stress leaves stable molecular imprints through epigenetic modifications in both the nuclear genome (e.g., NR3C1, MECP2 methylation, H3K27ac) and mitochondria (e.g., mtDNA methylation) (Stoccoro and Coppedè, 2021; ; Sanacora et al., 2022; ). These changes modulate expression of mitophagy regulators (e.g., PINK1, Parkin, NIX, BNIP3), establishing persistent mitochondrial alterations that increase cellular vulnerability to subsequent stress. The causal chain of this “initial molecular imprint” requires further testing in controlled experiments and longitudinal population studies. Together, these signaling and epigenetic events form the early mechanism by which stress “programs” mitochondrial function. Even after stress resolution, these mitochondrial and genetic imprints persistently alter cellular metabolism and autophagy capacity, laying the foundation for life-long dynamic changes in mitophagy.
FIGURE 1
3 Cellular heterogeneity of stress-induced mitophagy: distinct roles in neurons and glia
The CNS is highly vulnerable to pathological stress. Chronic stress drives profound biochemical alterations, synaptic remodeling, and neural dysfunction (). Within the complex brain microenvironment, neural network integrity depends on precise metabolic and immune crosstalk between neurons and glia (Soto et al., 2023). Mitophagy is regulated in a strongly cell-type-specific manner, yielding distinct outcomes across CNS cell populations.
3.1 Axonal/dendritic subdomain-specific mitophagy in neurons and its lifespan dynamics
Neuronal survival and complex electrophysiological activity rely heavily on ATP produced by mitochondria. Mitochondrial dysfunction is an early trigger of neuronal degeneration and death (Song et al., 2023; Zhao et al., 2024). The unique polarized structure of neurons restricts mitophagy to distinct subcellular regions. Most mitochondria in mature neurons localize to distal dendrites and axons, far from the lysosome-rich soma. The health and precise distribution of these local mitochondria directly determine synaptic integrity ().
Under physiological conditions or mild acute stress, neurons maintain rapid mitochondrial turnover via local mitophagy (). When focal mitochondrial damage occurs in hippocampal axons, mitochondrial Rho GTPase (Miro) is rapidly ubiquitinated and degraded. This blocks dynein-dependent retrograde transport and “traps” damaged mitochondria in place (; ). The outer membrane damage sensors PINK1 and Parkin then accumulate locally, together with LC3-positive autophagosomes and Lysosome-associated Membrane Protein 1 (LAMP1) - positive lysosomes, to clear damaged organelles in situ and suppress oxidative cascades (Martinez et al., 2017; ). A parallel PINK1–Parkin-independent pathway also operates. For example, mitochondrial E3 ubiquitin ligase 1 (MUL1/Mulan) can clear damaged mitochondria autonomously when PINK1 is absent (McWilliams et al., 2018).
Because neurons are post-mitotic and irreplaceable throughout life, mitophagy is essential for managing proteotoxic stress and maintaining homeostasis in distal compartments (Stavoe and Holzbaur, 2019), and it changes markedly with age. In mouse models of cerebral ischemia, ischemic stress or high exogenous GCs modify proliferation-associated 2G4 (PA2G4)/ErbB3-binding protein 1 (EBP1). PA2G4/EBP1 undergoes in situ ubiquitination, disrupting its interaction with p62 and inhibiting synaptic mitophagy, which restricts dendritic cytoskeletal development (). These findings suggest that GCs suppress axonal/dendritic mitophagy across multiple stages of neural development. Pregnancy is a critical window for neuronal maturation. High GCs levels caused by maternal stress may similarly inhibit dendritic and axonal mitophagy, impairing neuronal development and synapse formation, and thereby increasing vulnerability to later neurodevelopmental disorders.
3.2 Synaptic pruning by astrocytes and APOE4-Mediated autophagic flux blockade
Astrocytes are the most abundant glial cells in the CNS. They provide essential energetic support for synaptic transmission through lactate shuttling and glutamine secretion (Miyamoto et al., 2019).
Astrocyte proliferation, differentiation, and maturation peak from birth through late childhood in humans (corresponding to the first three postnatal weeks in rodents), a key period for brain development (Vivi et al., 2023). This window overlaps with active synaptogenesis. Astrocytes tightly regulate the balance between synapse formation and elimination, helping to establish functional neural networks (Vivi et al., 2023; Vivi and Di Benedetto, 2024). In mice, astrocytes target glutamatergic synapses and promote synaptic pruning via the Multiepidermal Growth Factor-like domain protein 10 (MEGF10) - mediated phagocytic pathway throughout development and adulthood. Knockdown of the Drosophila homolog of phosphatidylserine impairs synaptic pruning, supporting evolutionary conservation of this mechanism (Nelson and Broadie, 2025).
APOE4 is the strongest genetic risk factor for late-onset AD (). In vitro and pathological evidence link APOE4 to defective astrocytic mitophagy. In APOE4-carrying astrocytes, abnormal accumulation of cholesterol and unesterified lipids in lysosomes impairs lysosomal acidification (due to reduced V-ATPase activity). This sharply reduces the docking efficiency of autophagy adaptors LC3/p62 to damaged mitochondria and weakens lysosomal substrate degradation (; ). APOE4-driven lysosomal lipid overload and autophagic arrest disrupt mitochondrial homeostasis and promote reactive astrogliosis and neuroinflammation in the aging brain (), reinforcing the central role of mitophagy failure in aging and AD pathogenesis.
3.3 Sentinel amplification of immune activation and “inflammaging” driven by impaired microglial mitophagy
Microglia are the resident immune cells of the CNS, acting as dual sentinels for environmental surveillance and synaptic pruning (Paolicelli et al., 2011). At the molecular level, collapse of microglial mitophagy triggers robust pro-inflammatory signaling. During chronic psychological stress or exposure to inflammatory toxins such as LPS, microglia show elevated mtDNA release and ROS production (Wang R. et al., 2024). Impaired mitophagy allows damaged mtDNA to leak into the cytosol, where it is detected by the pattern recognition receptor--cyclic GMP-AMP synthase (cGAS). This activates the downstream stimulator of interferon genes (STING)–interferon regulatory factor 3 (IRF3) pathway (West et al., 2015; Zhou et al., 2024). Concurrently, cytosolic ROS accumulation promotes assembly of the nucleotide-binding oligomerization domain-like receptor protein 3 (NLRP3) inflammasome, leading to robust maturation and release of pro-inflammatory cytokines including IL-1β and IL-18, and triggering a neuroinflammatory cascade (Thangaraj et al., 2020; ; Wang H. et al., 2024; Zhou et al., 2024).
Immune dysregulation caused by mitophagy failure in microglia leaves distinct, age-specific pathological signatures across the lifespan. In the fetal period, external insults such as zinc oxide nanoparticles activate the E3 ubiquitin ligase mouse double minute 2 (MDM2), which ubiquitinates the mitochondrial contact site and cristae organizing system complex (MICOS)--Mic60 protein (Zhang et al., 2023). Prenatal exposure to stimuli such as caffeine causes intrauterine growth restriction in rats, leading to excessive microglial activation and synaptic pruning, ASD-like behaviors, and hippocampal damage (Wang T. et al., 2023). Single-nucleus RNA sequencing of whole brain or prefrontal cortex tissue reveals that microglia in aged brains upregulate inflammatory genes and downregulate homeostatic markers (; Muralidharan et al., 2025), supporting a shift toward a pro-inflammatory phenotype with age. Quinolinic acid, a metabolite secreted by stressed microglia, is elevated in brain aging and age-related neurodegeneration. It impairs mitophagy and blocks mitolysosome formation (), locking microglia in a chronic pro-inflammatory state termed inflammaging. In this state, sustained cytokine release acts on nearby neurons and astrocytes, accelerating the deposition and spread of amyloid β (Aβ) and hyperphosphorylated tau. This drives severe progression of neurodegenerative diseases including AD and PD in older individuals (; Zhou et al., 2024).
Collectively, we propose an integrated “cell–age–stress” three-dimensional regulatory framework (Figure 2). High prenatal GC stress inhibits synaptic mitophagy in neurons by altering in situ ubiquitination of PA2G4/EBP1 and disrupting p62 binding, potentially contributing to neurodevelopmental disorders such as ASD. Prenatal insults also activate MDM2, triggering excessive autophagosome accumulation, aberrant glial activation, and exaggerated synaptic pruning, which lead to ASD-like phenotypes and hippocampal injury. The pro-inflammatory microglial phenotype dominates in late life, driven by metabolite-dependent impairment of lysosome formation. In astrocytes carrying the APOE4 allele, chronic inflammatory stress promotes mitochondrial collapse, lysosomal lipid overload, reduced V-ATPase activity, and inefficient docking and degradation of damaged mitochondria, accelerating AD and PD pathogenesis. In adolescence, astrocytic MEGF10-mediated phagocytosis promotes neuroinflammation and excessive synaptic pruning, increasing vulnerability to affective disorders.
FIGURE 2
4 Dynamic changes in mitophagy and stage-specific neuropathology
4.1 Fetal epigenetic programming and ASD vulnerability
Maternal stress elevates GCs levels. GCs cross the placental barrier, enter fetal circulation, and activate GR. Maternal stress exerts dual effects on fetal brain development, depending on stress type and intensity.
Prolonged exposure to high glucocorticoid levels destabilizes PINK1 on the outer mitochondrial membrane through GR signaling, suppresses PGC-1α activity, and ultimately impairs mitophagy. Reduced PGC-1α impairs mitochondrial synthesis and selectively lowers mitophagy, culminating in synaptic and neuronal damage (; ; ). On the other hand, prenatal stressors such as nicotine activate the general control nonderepressible 2 (GCN2) pathway in the placenta. The GCN2/ATF4 pathway senses mitochondrial stress and rewires neuronal metabolism by upregulating mitochondrial dysfunction markers and the epigenetic metabolite 2-hydroxyglutarate (2-HG) (Zhu et al., 2021). 2-HG is a mitochondrial metabolite best studied in cancer, its elevation reflects mitochondrial dysfunction or stress-induced metabolic remodeling. Lowering 2-HG alleviates stress-related neuronal deficits, while excess 2-HG worsens them (). In mouse models, maternal stress increases brain 2-HG, indicating concurrent collapse of mitochondrial and epigenetic homeostasis (). Upon stress-induced GCN2/ATF4 activation, 2-HG triggers compensatory BNIP3/NIX-dependent mitophagy. Although this response attempts to restore mitochondrial balance, it also raises ROS and may interfere with normal fetal development, warranting further investigation (Zhu et al., 2021). In summary, fetal exposure to maternal stress disrupts mitochondrial homeostasis via two main routes: prolonged GC exposure strongly inhibits mitophagy, and it also affects the development of synapses. Whereas the GCN2/ATF4 axis drives complex compensatory mitophagy, whether this pathway is associated with the CNS needs further verification.
The intergenerational transmission of stress mainly increases the risk of offspring developing ASD (). Key ASD-associated genes are functionally linked to mitophagy, including encoding gene of Parkin (PARK2), the activating molecule in BECLIN-1-regulated autophagy (AMBRA1), WD repeat and FYVE domain-containing 3 (WDFY3) and Cln three requiring 9 (CTR9). PARK2 is critical for synaptic function. AMBRA1 encodes a mitophagy receptor containing an LC3-interacting region (LIR), heterozygous AMBRA1 mutation in mice produces ASD-like behaviors (). WDFY3 encodes an adaptor that promotes autophagosome–lysosome fusion, its mutation disrupts neural development and synaptic plasticity (Napoli et al., 2018; Napoli et al., 2021). In a study of 13 mostly neonatal patients with heterozygous CTR9 variants, four were diagnosed with ASD (Meuwissen et al., 2022), consistent with CTR9’s conserved role in Drosophila neural development (). Meuwissen et al. also demonstrated that CTR9 regulates mitophagy and its association with neurodevelopment in yeast, consistent with this, CTR9 contributes to mitophagy induction (Zheng et al., 2020) We therefore hypothesize that CTR9 variants contribute to ASD pathogenesis by disrupting mitophagy. At present, although the association of the CTR9 gene with neurodevelopmental disorders is well-established (Meuwissen et al., 2022), the causal link between ASD-related genes and mitophagy remains to be validated.
4.2 Adolescent dynamic disruption and depression
Adolescence is a critical period for brain maturation. As cellular powerhouses, mitochondria shape synaptic formation and development across the CNS (Zhang Z. et al., 2024). Chronic social and environmental stress during adolescence activates transcription factor C/EBPβ in medial prefrontal cortical neurons, upregulates the mitochondrial fission protein dynamin-related protein 1 (DRP1), and triggers mitochondrial dysfunction, thereby increasing stress vulnerability (; ). Physiological DRP1 activation promotes mitochondrial fission and supports PINK1/Parkin-mediated mitophagy, this effect is amplified by PINK1-dependent DRP1 phosphorylation at Ser616 (). DRP1 function is bidirectional, and its dysregulation is pathogenic. On the one hand, DRP1 deletion or downregulation causes excessive mitochondrial fusion, ubiquitin and mitophagy marker accumulation, and neurodegeneration (Wang et al., 2020; Yi et al., 2022; Wen et al., 2025). On the other hand, under chronic stress, pathological DRP1 hyperactivation (high Ser616 phosphorylation, low Ser637 phosphorylation (Wang et al., 2020)) triggers excessive mitochondrial fragmentation, ATP depletion, and ROS overload (). Excessive fission promotes LC3II and SQSTM1/p62 buildup, blocks Parkin recruitment to damaged mitochondria, inhibits autophagosome–lysosome fusion, and stalls mitophagy (Yi et al., 2022; Wen et al., 2025). Tight DRP1 control is therefore essential for mitochondrial homeostasis, and its dysbalance is a key driver of adolescent stress-induced neural injury. Mitochondrial dysfunction and impaired mitophagy disrupt neuronal function and synaptic transmission (Zhang Z. et al., 2024), particularly along the pathway from the basolateral amygdala (BLA) to the bed nucleus of the stria terminalis (BNST) (; ), precipitating depression-like behaviors (; ; ).
Adolescent stress also impairs glial function. Mitochondrial damage in astrocytes contributes to neuronal toxicity (Yang et al., 2022; Yang et al., 2023). Stress inactivates mitofusin 2 (Mfn2), inhibiting PI3K/Akt/mTOR-dependent mitophagy in astrocytes (Yang et al., 2023). These glial defects amplify neuronal injury and inflammation, collectively establishing depressive circuits.
4.3 Senescent mitophagy-lysosome axis collapse and AD/PD
Mitochondrial dysfunction is a hallmark of aging (), and lysosome-dependent autophagic clearance supports longevity (Redmann et al., 2016; ). Aging directly impairs lysosome biogenesis and function via the mechanistic target of rapamycin (mTOR)/transcription factor EB (TFEB) pathway (Zhong et al., 2022), reducing mitophagy and allowing damaged mitochondria to accumulate. Aging also disrupts the HPA axis, triggering chronic low-grade inflammation and elevated GCs. High GC upregulates serum/glucocorticoid-regulated kinase 1 (SGK1). Inhibiting glial SGK1 suppresses the DNA sensor cGAS–STING pathway, reverses proinflammatory glial phenotypes, and reduces cellular senescence and mitochondrial damage (). Reverse inference suggests that the increase in glutamate levels may activate the cGAS-STING pathway, thereby triggering an inflammatory response in glial cells. GCs worsen mitochondrial injury and promote cytosolic release of mtDNA (Wang R. et al., 2024), and activate the cGAS–STING–IRF3 pathway, triggering sustained type I interferon responses. The cGAS–STING pathway also retrogradely promotes TFEB nuclear translocation to enhance lysosome biogenesis (Xu Y. et al., 2025). Together, these observations suggest that aging-related GC elevation creates a self-reinforcing cycle involving cGAS–STING–IRF3 and TFEB, generating an “autophagy–inflammation vicious cycle”.
In the adult brain, quiescent neural stem cells contain abundant lysosomes and can generate neural progenitors. With aging, these cells develop lysosomal dysfunction, increasing protein aggregation, suppressing stem cell activation (), and causing mitochondrial buildup. PD involves degeneration of dopaminergic neurons, driven by Lewy bodies that inhibit complex I, increase ROS, block mitochondrial transport to lysosomes (), and trigger mitochondrial dysfunction (Swerdlow and Wilkins, 2020; ). Chronic stress and GC dysregulation increase PD risk and accelerate progression by amplifying mitochondrial injury and inflammation (Wang R. et al., 2024). PD-linked mutations in α-synuclein (SNCA) and leucine-rich repeat kinase 2 (LRRK2) disrupt lysosomal pathways (). LRRK2 mutations increase mitochondrial fragmentation, reduce membrane potential, elevate calcium uptake, and block mitochondrial clearance in dendrites (). In aged LRRK2-R1441G mice, abnormal DRP1 signaling causes ubiquitinated mitochondrial buildup, lowers stress tolerance, and accelerates neuronal apoptosis (). Heightened stress sensitivity, combined with aging-related HPA dysregulation and chronic GC exposure, promotes neurodegeneration. Defective PINK1/Parkin/DJ-1-mediated mitophagy underlies autosomal recessive PD. DJ-1 acts with PINK1/Parkin to recruit autophagy receptors such as optineurin, loss of this interaction blocks mitophagy ().
AD is defined by extensive Aβ plaques and neurofibrillary tangles of hyperphosphorylated tau (Xie et al., 2022). Chronic stress and sustained high GC increase AD risk and accelerate cognitive decline by promoting Aβ deposition, tau hyperphosphorylation, and neuroinflammation (Zhuravleva et al., 2021; ). Impaired mitophagy initiation (e.g., low phospho-TBK1, phospho-ULK1) disrupts energy metabolism, exacerbates Aβ and tau accumulation, and triggers synaptic failure and cognitive impairment (; ; ). Age-related lysosomal dysfunction is the primary barrier to mitophagy initiation (Tan and Finkel, 2023), consistent with this finding, restoring lysosomal function in AD models removes abnormal mitochondria and preserves synaptic structure (). Damaged mitochondria also impair microglial clearance of neurotoxic proteins and dysregulate cytokine release (). This aligns with cGAS–STING-driven neuroinflammation induced by mitochondrial injury, forming a self-reinforcing pathological cycle linking mitochondrial–lysosomal dysfunction and neuroinflammation in age-related neurodegeneration.
As shown in Figure 3, the increase in GCs caused by maternal stress interferes with mitochondrial quality control through multiple mechanisms. Excessive GCs signals inhibit the PINK1/PGC1α pathway and damage mitophagy, resulting in impaired synaptic development. At the same time, the activated GCN2/ATF4 pathway induces compensatory mitophagy dependent on BNIP3/NIX, which has an unclear effect on synapses. However, related to this mechanism, mutations in mitophagy-related genes increase synaptic damage and the risk of ASD. During adolescence, chronic stress disrupts mitochondrial dynamics in a cell-specific manner. In medial prefrontal cortex neurons, stress-induced DRP1 hyperactivation promotes excessive mitochondrial fission and impairs autophagic flux by disrupting autophagosome–lysosome fusion. In parallel, suppression of Mfn2 signaling in astrocytes compromises mitochondrial network integrity and metabolic support. These alterations collectively impair synaptic remodeling and contribute to the development of depression-like phenotypes.
FIGURE 3
During aging, sustained high GCs cause lysosomal dysfunction, leading to collapse of the mitophagy–lysosome axis. Damaged mitochondria release mtDNA, which activates the cGAS–STING pathway and triggers persistent neuroinflammation, forming a self-reinforcing vicious cycle. This cycle ultimately promotes the accumulation of Aβ and hyperphosphorylated Tau in AD, as well as Lewy bodies in PD.
It is worth noting that the role of calcium in the pathogenesis of AD, ALS, and other diseases is beginning to emerge. Oligomeric Aβ exposure may be associated with mitochondrial calcium overload, and tau-mediated pathology is also linked to improper calcium handling, with mitochondrial calcium homeostasis disruption rendering neurons susceptible to excitotoxic damage (Verma et al., 2022). The previous description of Ca2+ influencing mitophagy through the regulation of MMP may explain this. Consistent with our hypothesis, primary cortical neurons transfected with LRRK2 exhibit increased calcium influx, which is mediated by the transcriptional upregulation of the mitochondrial calcium uniporter (MCU) and the mitochondrial calcium uptake one protein (MICU1) (Verma et al., 2017).
5 Mitochondria-to-nucleus mitokine feedback: epigenetic retrograde signaling
We have described how psychological stress elevates GCs release, disrupts mitochondrial homeostasis, and triggers a forward stress injury cascade marked by mitophagy failure and damaged mitochondria accumulation. This section focuses on the long-underappreciated reverse relationship: mitochondria-to-nucleus retrograde communication. When mitophagy is impaired across life stages, dysfunctional mitochondria act as active signaling hubs that retrogradely control nuclear gene expression (). Uncleared mtDNA, specific metabolites such as 2-HG, and local ROS translocate to or signal within the nucleus, dynamically reshaping the host epigenetic landscape.
5.1 Metabolites as epigenetic signals
Mitochondria generate multiple central cellular metabolites, including succinate and α-ketoglutarate (α-KG) from TCA cycle. These metabolites modulate DNA methylation by inhibiting α-KG-dependent DNA demethylases ().
2-HG is a mitochondrial metabolite that acts as a competitive inhibitor of α-KG and DNA demethylases (). In anti-tumor T-cell immunity, 2-HG strongly increases the key histone methylation mark histone H3 lysine 27 trimethylation (H3K27me3) (Yang et al., 2025). Mechanistically, 2-HG competitively binds α-KG to inhibit the Jumonji-C (JmjC) family of lysine demethylases (KDMs), the Ten-Eleven Translocation (TET) family of 5′-methylcytosine hydroxylases, the Alkylation B (AlkB) family of Fe(II)/α-ketoglutarate-dependent dioxygenases, and the egg-laying defective nine (EGLN, also known as PHD) enzymes, leading to global histone hypermethylation ().
These observations suggest that prenatal psychological stress-induced 2-HG elevation may drive hypermethylation of neurodevelopmental genes, thereby promoting ASD pathogenesis. In secondary glioblastoma, isocitrate dehydrogenase (IDH) mutations produce 2-HG, establishing a unique genome-wide hypermethylation profile termed the glioma CpG island methylator phenotype (G-CIMP), which drives tumorigenesis (Yamashita et al., 2019). In neural stem cells, 2-HG also reduces acetyl-CoA (Ac-CoA) levels (). Ac-CoA is an essential substrate for histone acetylation--e.g., histone H3 lysine 27 acetylation (H3K27ac), mitochondrial changes in Ac-CoA can therefore retrogradely alter nuclear histone acetylation (Sun et al., 2024), further supporting our hypothesis.
5.2 Signaling roles of ROS
Dysfunctional mitochondria downregulate nuclear-encoded oxidative phosphorylation genes and activate the ROS–JNK mitochondria-to-nucleus retrograde pathway. This will trigger the formation of cytoplasmic chromatin fragments (CCFs) and induce senescence-related secretory phenotypes. CCFs are rich in heterochromatin markers, such as the methylation markers H3K9me3 and H3K27me3 (Vizioli et al., 2020). These findings suggest that the ROS-JNK pathway may be related to methylation changes.
While excessive ROS causes cellular damage, ROS also functions as a critical signaling molecule that activates multiple pathways, including those regulating epigenetic enzymes (Mostafavi Abdolmaleky and Zhou, 2024). High ROS levels modulate the activities of histone acetyltransferases (HATs), histone deacetylases (HDACs), and DNA methyltransferases (DNMTs), thereby epigenetically controlling gene expression ().
5.3 Signaling roles of mtDNA and mitochondrial RNA (mtRNA) fragments
Upon mitochondrial damage or dysfunction, mtDNA are released into the cytoplasm and may enter the nucleus (Wang et al., 2026). Mitochondria-derived long non-coding RNAs (mtlncRNAs) translocate from mitochondria to the nucleus, with RNA-binding proteins HuR and PNPT1 serving key roles in this process (). These mitochondrial nucleic acids are detected by pattern recognition receptors (PRRs) such as the cGAS–STING pathway, triggering inflammatory and interferon responses that indirectly reshape the epigenetic landscape (; ; Wang et al., 2026).
Methylation and hydroxymethylation marks are widely present in the mtDNA genome (Zhang F. et al., 2024) and contribute to mitochondrial injury in multiple human diseases, including neurodegenerative disorders (Stoccoro and Coppedè, 2021). MtDNA N6-methyldeoxyadenosine (6 mA) modification plays critical roles in aging and neurodegeneration (Zhang L. et al., 2024; Zhang L. et al., 2025). Notably, in vascular cognitive impairment, the 6-mA methylation mediated by methyltransferase (METTL4) in mtDNA drives neuroinflammation through cGAS-STING activation ().
As shown in Figure 4, when mitophagy is impaired, dysfunctional mitochondria are no longer passive victims of cellular damage but become active signaling hubs that reshape the host’s epigenetic landscape through mitochondria-to-nucleus retrograde signaling, this feedback relies on three types of mitochondrial signals. Among these, stress-induced 2-HG plays two roles. On one hand, it competitively binds to α-KG and inhibits demethylases, promoting global hypermethylation. On the other hand, it lowers Ac-CoA levels to exert an inhibitory effect on histone acetylation.
FIGURE 4
Stress-induced mitochondrial damage activates the ROS-JNK retrograde signaling pathway from mitochondria to the nucleus, leading to the formation of CCFs and the development of senescence-associated secretory phenotype, and further epigenetic changes such as methylation. High ROS levels regulate the activity of HATs, HDACs, DNMTs, thereby controlling gene expression at the epigenetic level. Upon mitochondrial damage and dysfunction, mtDNA translocates into the nucleus, where methyltransferase METTL4 catalyzes 6-mA methylation of mtDNA to activate the cGAS-STING pathway and trigger neuroinflammation. The mtlncRNAs are shuttled into the nucleus with the assistance of RNA-binding proteins HuR and PNPT1, and also initiate inflammatory and interferon responses via the same cGAS-STING signaling cascade.
6 Therapeutic perspectives: precision interventions across the lifespan
Strategies targeting mitochondrial quality control across the lifespan must not blindly and globally activate mitophagy. Non-specific over-activation can cause severe adverse effects, such as damaging healthy mitochondria or triggering cell death. Therefore, based on the “cell-age-stress” three-dimensional framework discussed earlier, we propose a “lifespan intervention hypothesis.” This involves targeted interventions on the “stress-mitophagy-CNS regulatory axis” during critical developmental windows to develop individualized and spatiotemporally specific strategies.
6.1 The fetal stage and ASD: blocking endocrine cascades and erasing epigenetic marks
The fetal and early postnatal periods are the most vulnerable windows for neurogenesis and synaptic network formation. High levels of GCs and abnormal accumulation of the metabolite 2-HG, triggered by maternal prenatal stress, leave profound “epigenetic marks” on both mitochondria and the nucleus. This suppresses mitophagy, induces microglial overactivation, and causes aberrant synaptic pruning, ultimately increasing the risk of ASD.
Currently, effective early interventions for ASD mostly focus on correcting HPA axis overactivation. For example, sodium butyrate can significantly increase histone acetylation at the corticotropin-releasing hormone receptor 2 (CRHR2) promoter region, restoring the HPA axis negative feedback loop via epigenetic mechanisms (Wang X. et al., 2023). Furthermore, moderate pharmacological inhibition of the GR signaling pathway during pregnancy can restore normal astrocyte differentiation and alleviate ASD-like behavioral deficits in offspring (Yuan et al., 2026).
However, past studies on the direct role of 2-HG in neurodevelopment are limited. Recent evidence indicates that abnormal accumulation of 2-HG can epigenetically activate MYC (a core member of the bHLH transcription factor family), thereby blocking neuronal differentiation (). Furthermore, in neuropathological models like amyotrophic lateralizing sclerosis (ALS), MYC-driven glial abnormalities severely disrupt neuron-glia communication (). Therefore, targeting the abnormal production of 2-HG or blocking its downstream epigenetic activation of MYC holds promise as a novel therapeutic target. This approach could erase stress-induced “initial molecular marks” at the source, rescue synaptic development, and help treat early ASD.
6.2 Adolescence and depression: restoring mitochondrial dynamics and quenching retrograde ROS signals
Adolescence is a critical period for prefrontal cortex maturation, fine synaptic pruning, and the consolidation of emotion regulation networks. Chronic stress during this time specifically upregulates DRP1 expression, leading to excessive mitochondrial fission and fragmentation in neurons, accompanied by a massive accumulation of ROS. Acting as retrograde signals, these ROS not only induce nuclear epigenetic changes but also exacerbate excessive synaptic pruning by astrocytes, ultimately consolidating pathological depressive neural circuits.
Therapeutically, targeting the dynamic balance of DRP1 is a primary strategy for treating adolescent depression (). Notably, abnormal ROS activation in adolescent mice is a core driver of impaired synaptic plasticity and neurobehavioral abnormalities (Zhang C. et al., 2025). Future antidepressant therapies should develop treatments targeting mitochondrial ROS. By cutting off this key “retrograde danger signal,” such treatments may effectively prevent aberrant synaptic engulfment by adolescent astrocytes (such as that mediated by MEGF10) and protect vulnerable affective and cognitive circuits.
6.3 Aging and PD/AD: unblocking lysosomal autophagic flux
Under conditions of aging and chronic stress accumulation, the “mitophagy-lysosome regulatory axis” in the CNS faces complete collapse. On one hand, lysosomal lipid overload prevents the degradation of autophagosomes. On the other hand, un-cleared damaged mitochondria release large amounts of mtDNA into the cytoplasm, activating the cGAS/STING pathway in microglia. This triggers a state of inflammaging, a phenomenon highly correlated with the accelerated clinical progression of neurodegenerative diseases like AD and PD.
Therapeutically, the core issue in the aging neurodegenerative brain lies in the stagnation of downstream lysosomal degradation. Using metabolic regulators such as Urolithin A can restore lysosomal acidification and degradation functions via caspase-related pathways. This process is crucial for clearing the abnormal accumulation of Aβ and Tau proteins and for alleviating AD symptoms ().
Meanwhile, the link between mtDNA mutations and aging opens new avenues for delaying aging and treating related diseases (Xu X. et al., 2025). Studies confirm that enhancing mitophagy can significantly reduce the activation of the cGAS/STING pathway driven by intracellular free mtDNA (). Therefore, in addition to repairing the autophagy-lysosome network, developing small-molecule drugs to specifically block mtDNA-cGAS binding, or inhibiting the overactivation of STING and its downstream pathways, could fundamentally reverse the microglial pro-inflammatory phenotype. This presents a highly promising new approach of “dual immune-metabolic intervention” for delaying aging and treating neurodegenerative diseases in the elderly.
7 Conclusion and perspective
This review focuses on how stress impacts the CNS through mitophagy across the lifespan. We highlight that psychological stress disrupts mitochondrial quality control through HPA-axis activation and glucocorticoid signaling, leading to persistent alterations in mitophagy across the lifespan. Meanwhile, signaling molecules released by damaged mitochondria—including 2-HG, ROS, and mtDNA—exert retrograde regulation over nuclear epigenetic landscapes.
We summarize the dynamic evolution of mitophagy in three key life stages: Fetal period--Maternal stress elevates GC levels, suppresses mitophagy, impairs neurodevelopment, and increases vulnerability to ASD and other neurodevelopmental disorders. Adolescence--Stress disturbs mitochondrial dynamics and mitophagy, disrupts synaptic remodeling, and raises the risk of affective disorders. Aging-The mitophagy–lysosome axis collapses, cumulative stress effects escalate, and susceptibility to AD, PD, and other neurodegenerative diseases rises sharply.
We further establish an integrated cell–age–stress three-dimensional regulatory framework involving neurons, astrocytes, and microglia under distinct age and stress conditions. Finally, we propose the lifespan intervention hypothesis, which emphasizes precision fine-tuning strategies during critical developmental windows, with strong potential for clinical translation.
Notably, this review delineates both the forward stress injury (mitophagy failure and damaged mitochondrial accumulation) and mitochondria-to-nucleus retrograde signaling. We emphasize the mechanisms by which unresolved mtDNA, 2-HG, and ROS translocate to the nucleus to drive epigenetic remodeling, clarifying the bidirectional regulatory axis underlying stress-mitochondria interactions.
However, several critical questions remain unresolved. The precise pathways by which damaged mitochondria transmit signals to the nucleus and direct epigenetic reprogramming are not fully defined. Identifying cell-specific and lifespan-specific sensors, effectors, and downstream epigenetic modifications remains a major challenge. More provocatively, whether this mechanism forms the basis of transgenerational inheritance remains a highly speculative hypothesis that warrants future multi-generational tracing studies.
Emerging evidence also indicates heightened vulnerability in regions such as the fetal temporal lobe and adolescent prefrontal cortex. A key unanswered question—and a central hypothesis for future research—is whether stress primarily impairs mitophagy in neurons within these critical circuits to directly compromise synaptic integrity, or whether initial damage targets specialized glia, whose subsequent dysfunction and inflammatory output drive regional network failure.
In summary, this review of the age-stratified stress–mitophagy–CNS axis establishes a key mechanistic framework centered on mitochondria–nucleus bidirectional regulation and introduces a novel three-dimensional regulatory model. Together, these insights provide promising directions for mechanistic research and future clinical translation.
Statements
Author contributions
MW: Writing – original draft, Writing – review and editing. ZZ: Data curation, Writing – original draft. ZS: Conceptualization, Writing – original draft. FZ: Data curation, Writing – original draft. KB: Writing – review and editing.
Funding
The author(s) declared that financial support was received for this work and/or its publication. This work was supported by the National Natural Science Foundation of China (82204714), the Supporting Funds for the Youth Program of the National Natural Science Foundation of Nanjing University of Chinese Medicine (XPT82204714), the Open Project of Chinese Materia Medica First-Class Discipline of Nanjing University of Chinese Medicine (No. ZYXYL2024-009), and the National Natural Science Foundation of China (824B2067).
Conflict of interest
The author(s) declared that this work was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Generative AI statement
The author(s) declared that generative AI was not used in the creation of this manuscript.
Any alternative text (alt text) provided alongside figures in this article has been generated by Frontiers with the support of artificial intelligence and reasonable efforts have been made to ensure accuracy, including review by the authors wherever possible. If you identify any issues, please contact us.
Publisher’s note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.
References
1
Abellán-ÁlvaroM.StorkO.Agustín-PavónC.SantosM. (2021). MeCP2 haplodeficiency and early-life stress interaction on anxiety-like behavior in adolescent female mice. J. Neurodev. Disord.13 (1), 59. 10.1186/s11689-021-09409-7
2
Ahmed SelimN.WojtovichA. P. (2025). Mitochondrial membrane potential and compartmentalized signaling: calcium, ROS, and beyond. Redox Biol.86, 103859. 10.1016/j.redox.2025.103859
3
AlhassenS.ChenS.AlhassenL.PhanA.KhoudariM.De SilvaA.et al (2021). Intergenerational trauma transmission is associated with brain metabotranscriptome remodeling and mitochondrial dysfunction. Commun. Biol.4 (1), 783. 10.1038/s42003-021-02255-2
4
ArtyukhovaM. A.TyurinaY. Y.ChuC. T.ZharikovaT. M.BayırH.KaganV. E.et al (2019). Interrogating Parkinson’s disease associated redox targets: potential application of CRISPR editing. Free Radic. Biol. Med.144, 279–292. 10.1016/j.freeradbiomed.2019.06.007
5
AshrafiG.SchleheJ. S.LaVoieM. J.SchwarzT. L. (2014). Mitophagy of damaged mitochondria occurs locally in distal neuronal axons and requires PINK1 and Parkin. J. Cell Biol.206 (5), 655–670. 10.1083/jcb.201401070
6
AshwaniSharmaA.ChoudharyM. K.GugulothuD.PanditaD.VermaS.et al (2025). Epigenetic and mitochondrial metabolic dysfunction in multiple sclerosis: a review of herbal drug approaches and current clinical trials. Mol. Neurobiol.62 (8), 10045–10090. 10.1007/s12035-025-04868-8
7
AugerJ. P.ZimmermannM.FaasM.StifelU.ChambersD.KrishnacoumarB.et al (2024). Metabolic rewiring promotes anti-inflammatory effects of glucocorticoids. Nature629 (8010), 184–192. 10.1038/s41586-024-07282-7
8
BahrampourS.ThorS. (2016). Ctr9, a key component of the Paf1 complex, affects proliferation and terminal differentiation in the developing drosophila nervous system. G3 (Bethesda)6 (10), 3229–3239. 10.1534/g3.116.034231
9
BaldelliS.AquilanoK.CirioloM. R. (2014). PGC-1α buffers ROS-mediated removal of mitochondria during myogenesis. Cell Death Dis.5 (11), e1515. 10.1038/cddis.2014.458
10
BartlettE. A.KleinD. N.LiK.DeLorenzoC.KotovR.PerlmanG. (2019). Depression severity over 27 months in adolescent girls is predicted by stress-linked cortical morphology. Biol. Psychiatry86 (10), 769–778. 10.1016/j.biopsych.2019.04.027
11
BorscheM.PereiraS. L.KleinC.GrünewaldA. (2021). Mitochondria and Parkinson’s disease: clinical, molecular, and translational aspects. J. Park. Dis.11 (1), 45–60. 10.3233/jpd-201981
12
BurkeM. R.SotiropoulosI.WaitesC. L. (2024). The multiple roles of chronic stress and glucocorticoids in Alzheimer’s disease pathogenesis. Trends Neurosci.47 (11), 933–948. 10.1016/j.tins.2024.08.015
13
CaoC.ChenM.YangS.XuY.GuJ. (2024). Childhood maltreatment, multilocus HPA-axis genetic variation and adolescent comorbidity profiles of depressive and anxiety symptoms. Child. Abuse Negl.149, 106683. 10.1016/j.chiabu.2024.106683
14
CarrierM.ŠimončičováE.St-PierreM. K.McKeeC.TremblayM. (2021). Psychological stress as a risk factor for accelerated cellular aging and cognitive decline: the involvement of Microglia-Neuron crosstalk. Front. Mol. Neurosci.14, 749737. 10.3389/fnmol.2021.749737
15
ChamoliM.RaneA.FoulgerA.ChintaS. J.ShahmirzadiA. A.KumstaC.et al (2023). A drug-like molecule engages nuclear hormone receptor DAF-12/FXR to regulate mitophagy and extend lifespan. Nat. Aging3 (12), 1529–1543. 10.1038/s43587-023-00524-9
16
ChanJ. C.NugentB. M.BaleT. L. (2018). Parental advisory: maternal and paternal stress can impact offspring neurodevelopment. Biol. Psychiatry83 (10), 886–894. 10.1016/j.biopsych.2017.10.005
17
ChangS.YimS.ParkH. (2019). The cancer driver genes IDH1/2, JARID1C/KDM5C, and UTX/KDM6A: crosstalk between histone demethylation and hypoxic reprogramming in cancer metabolism. Exp. Mol. Med.51 (6), 1–17. 10.1038/s12276-019-0230-6
18
ChenH.XuR.WangJ.GaoF.LvY.LiX.et al (2025). Maternal behavior promotes resilience to adolescent stress in mice through a microglia-neuron axis. Nat. Commun.16 (1), 2333. 10.1038/s41467-025-57810-w
19
ChoiG. E.LeeH. J.ChaeC. W.ChoJ. H.JungY. H.KimJ. S.et al (2021). BNIP3L/NIX-mediated mitophagy protects against glucocorticoid-induced synapse defects. Nat. Commun.12 (1), 487. 10.1038/s41467-020-20679-y
20
CongJ.LiuL.ShiR.HeM.AnY.FengX.et al (2025). NR3C1/GLMN-Mediated FKBP12.6 ubiquitination disrupts calcium homeostasis and impairs mitochondrial quality control in stress-induced myocardial damage. Int. J. Mol. Sci.26 (17), 8245. 10.3390/ijms26178245
21
CullenA. E.FisherH. L.GulletN.FraserE. R.RobertsR. E.ZahidU.et al (2022). Cortisol levels in childhood associated with emergence of attenuated psychotic symptoms in early adulthood. Biol. Psychiatry91 (2), 226–235. 10.1016/j.biopsych.2021.08.009
22
De PlanoL. M.SaittaA.OddoS.CaccamoA. (2024). Epigenetic changes in Alzheimer’s disease: DNA methylation and histone modification. Cells13 (8), 719. 10.3390/cells13080719
23
DengD.CuiY.GanS.XieZ.CuiS.CaoK.et al (2022). Sinisan alleviates depression-like behaviors by regulating mitochondrial function and synaptic plasticity in maternal separation rats. Phytomedicine106, 154395. 10.1016/j.phymed.2022.154395
24
DingZ.WangR.LiY.WangX. (2025). MLKL activates the cGAS-STING pathway by releasing mitochondrial DNA upon necroptosis induction. Mol. Cell85 (13), 2610–2625.e2615. 10.1016/j.molcel.2025.06.005
25
DongolA.ChenX.ZhengP.SeyhanZ. B.HuangX. F. (2023). Quinolinic acid impairs mitophagy promoting microglia senescence and poor healthspan in C. elegans: a mechanism of impaired aging process. Biol. Direct18 (1), 86. 10.1186/s13062-023-00445-y
26
DoserR. L.AmbergG. C.HoerndliF. J. (2020). Reactive oxygen species modulate activity-dependent AMPA receptor transport in C. Elegans. J. Neurosci.40 (39), 7405–7420. 10.1523/jneurosci.0902-20.2020
27
DuanK.GuQ.PetraliaR. S.WangY. X.PanjaD.LiuX.et al (2021). Mitophagy in the basolateral amygdala mediates increased anxiety induced by aversive social experience. Neuron109 (23), 3793–3809.e3798. 10.1016/j.neuron.2021.09.008
28
EldeebM. A.FallahiA.SoumbasisA.BayneA. N.TrempeJ. F.FonE. A. (2024). Mitochondrial import stress and PINK1-mediated mitophagy: the role of the PINK1-TOMM-TIMM23 supercomplex. Autophagy20 (8), 1903–1905. 10.1080/15548627.2024.2340399
29
EranS.RonitP. K. (2022). APOE4 expression is associated with impaired autophagy and mitophagy in astrocytes. Neural Regen. Res.17 (4), 777–778. 10.4103/1673-5374.322452
30
FanY.ChenZ.WangH.JiangM.LuH.WeiY.et al (2025). Isovitexin targets SIRT3 to prevent steroid-induced osteonecrosis of the femoral head by modulating mitophagy-mediated ferroptosis. Bone Res.13 (1), 18. 10.1038/s41413-024-00390-0
31
FangE. F.HouY.PalikarasK.AdriaanseB. A.KerrJ. S.YangB.et al (2019). Mitophagy inhibits amyloid-β and tau pathology and reverses cognitive deficits in models of Alzheimer’s disease. Nat. Neurosci.22 (3), 401–412. 10.1038/s41593-018-0332-9
32
Figueiredo-PereiraC.Villarejo-ZoriB.CiprianoP. C.TavaresD.Ramírez-PardoI.BoyaP.et al (2023). Carbon monoxide stimulates both mitophagy and mitochondrial biogenesis to mediate protection against oxidative stress in astrocytes. Mol. Neurobiol.60 (2), 851–863. 10.1007/s12035-022-03108-7
33
FiorettiP. V.BarbieriA.MigazziA.BressanD.GrassanoM.DoniniL.et al (2026). MYC-driven gliosis impairs neuron-glia communication in amyotrophic lateral sclerosis. Brain149 (5), 1604–1622. 10.1093/brain/awaf360
34
FurthN.CohenN.SpitzerA.SalameT. M.DassaB.MehlmanT.et al (2025). Oncogenic IDH1(mut) drives robust loss of histone acetylation and increases chromatin heterogeneity. Proc. Natl. Acad. Sci. U. S. A.122 (1), e2403862122. 10.1073/pnas.2403862122
35
GardnerA.BolesR. G. (2011). Beyond the serotonin hypothesis: Mitochondria, inflammation and neurodegeneration in major depression and affective spectrum disorders. Prog. Neuropsychopharmacol. Biol. Psychiatry35 (3), 730–743. 10.1016/j.pnpbp.2010.07.030
36
GeP.DawsonV. L.DawsonT. M. (2020). PINK1 and Parkin mitochondrial quality control: a source of regional vulnerability in Parkinson’s disease. Mol. Neurodegener.15 (1), 20. 10.1186/s13024-020-00367-7
37
GirottiM.BulinS. E.CarrenoF. R. (2024). Effects of chronic stress on cognitive function - from neurobiology to intervention. Neurobiol. Stress33, 100670. 10.1016/j.ynstr.2024.100670
38
GongY.ChaiY.DingJ. H.SunX. L.HuG. (2011). Chronic mild stress damages mitochondrial ultrastructure and function in mouse brain. Neurosci. Lett.488 (1), 76–80. 10.1016/j.neulet.2010.11.006
39
GongZ.ChenZ.SangS.YangL.QinH.LiQ.et al (2026). Mitochondrial DNA 6 mA methylation by METTL4 drives neuroinflammation via cGAS-STING activation in vascular cognitive impairment. Free Radic. Biol. Med.246, 1–16. 10.1016/j.freeradbiomed.2026.01.019
40
GuW.WangX.SolmonsonA.CaiL.XiaoY.TasdoganA.et al (2026). l-2-Hydroxyglutarate impairs neuronal differentiation through epigenetic activation of MYC expression. J. Clin. Invest136 (9), e197010. 10.1172/jci197010
41
HaasA.BorsookD.AdlerG.FreemanR. (2022). Stress, hypoglycemia, and the autonomic nervous system. Auton. Neurosci.240, 102983. 10.1016/j.autneu.2022.102983
42
HanH.TanJ.WangR.WanH.HeY.YanX.et al (2020). PINK1 phosphorylates Drp1(S616) to regulate mitophagy-independent mitochondrial dynamics. EMBO Rep.21 (8), e48686. 10.15252/embr.201948686
43
HanS.ZhangM.JeongY. Y.MargolisD. J.CaiQ. (2021). The role of mitophagy in the regulation of mitochondrial energetic status in neurons. Autophagy17 (12), 4182–4201. 10.1080/15548627.2021.1907167
44
HanX.XuT.FangQ.ZhangH.YueL.HuG.et al (2021). Quercetin hinders microglial activation to alleviate neurotoxicity via the interplay between NLRP3 inflammasome and mitophagy. Redox Biol.44, 102010. 10.1016/j.redox.2021.102010
45
HaoJ.HuangZ.ZhangS.SongK.WangJ.GaoC.et al (2024). Deciphering the multifaceted roles and clinical implications of 2-hydroxyglutarate in cancer. Pharmacol. Res.209, 107437. 10.1016/j.phrs.2024.107437
46
HaynesP. R.PyfromE. S.LiY.SteinC.CuddapahV. A.JacobsJ. A.et al (2024). A neuron-glia lipid metabolic cycle couples daily sleep to mitochondrial homeostasis. Nat. Neurosci.27 (4), 666–678. 10.1038/s41593-023-01568-1
47
HeoJ. M.OrdureauA.PauloJ. A.RinehartJ.HarperJ. W. (2015). The PINK1-PARKIN mitochondrial Ubiquitylation pathway drives a program of OPTN/NDP52 recruitment and TBK1 activation to promote mitophagy. Mol. Cell60 (1), 7–20. 10.1016/j.molcel.2015.08.016
48
HouY.ChuX.ParkJ. H.ZhuQ.HussainM.LiZ.et al (2024). Urolithin A improves Alzheimer’s disease cognition and restores mitophagy and lysosomal functions. Alzheimers Dement.20 (6), 4212–4233. 10.1002/alz.13847
49
HuntR. J.GranatL.McElroyG. S.RanganathanR.ChandelN. S.BatemanJ. M. (2019). Mitochondrial stress causes neuronal dysfunction via an ATF4-dependent increase in L-2-hydroxyglutarate. J. Cell Biol.218 (12), 4007–4016. 10.1083/jcb.201904148
50
HwangI.KimB. S.LeeH. Y.ChoS. W.LeeS. E.AhnJ. Y. (2024). PA2G4/EBP1 ubiquitination by PRKN/PARKIN promotes mitophagy protecting neuron death in cerebral ischemia. Autophagy20 (2), 365–379. 10.1080/15548627.2023.2259215
51
HyerM. M.ShawG. A.GoswameeP.DyerS. K.BurnsC. M.SorianoE.et al (2021). Chronic adolescent stress causes sustained impairment of cognitive flexibility and hippocampal synaptic strength in female rats. Neurobiol. Stress14, 100303. 10.1016/j.ynstr.2021.100303
52
ImberechtsD.KinnartI.WautersF.TerbeekJ.MandersL.WierdaK.et al (2022). DJ-1 is an essential downstream mediator in PINK1/parkin-dependent mitophagy. Brain145 (12), 4368–4384. 10.1093/brain/awac313
53
Jiménez-LoygorriJ. I.Villarejo-ZoriB.Viedma-PoyatosÁ.Zapata-MuñozJ.Benítez-FernándezR.Frutos-LisónM. D.et al (2024). Mitophagy curtails cytosolic mtDNA-dependent activation of cGAS/STING inflammation during aging. Nat. Commun.15 (1), 830. 10.1038/s41467-024-45044-1
54
JinK.YaoZ.van VelthovenC. T. J.KaplanE. S.GlattfelderK.BarlowS. T.et al (2025). Brain-wide cell-type-specific transcriptomic signatures of healthy ageing in mice. Nature638, 182–196. 10.1038/s41586-024-08350-8
55
KerrJ. S.AdriaanseB. A.GreigN. H.MattsonM. P.CaderM. Z.BohrV. A.et al (2017). Mitophagy and Alzheimer’s disease: cellular and molecular mechanisms. Trends Neurosci.40 (3), 151–166. 10.1016/j.tins.2017.01.002
56
KimS. Y.AdhikariA.LeeS. Y.MarshelJ. H.KimC. K.MalloryC. S.et al (2013). Diverging neural pathways assemble a behavioural state from separable features in anxiety. Nature496 (7444), 219–223. 10.1038/nature12018
57
KingsburyM.WeeksM.MacKinnonN.EvansJ.MahedyL.DykxhoornJ.et al (2016). Stressful life events during pregnancy and offspring depression: evidence from a prospective cohort study. J. Am. Acad. Child. Adolesc. Psychiatry55 (8), 709–716.e702. 10.1016/j.jaac.2016.05.014
58
KinnairdA.ZhaoS.WellenK. E.MichelakisE. D. (2016). Metabolic control of epigenetics in cancer. Nat. Rev. Cancer16 (11), 694–707. 10.1038/nrc.2016.82
59
KinnartI.MandersL.HeyninckT.ImberechtsD.PraschbergerR.SchoovaertsN.et al (2024). Elevated α-synuclein levels inhibit mitophagic flux. NPJ Park. Dis.10 (1), 80. 10.1038/s41531-024-00696-0
60
KlemmensenM. M.BorrowmanS. H.PearceC.PylesB.ChandraB. (2024). Mitochondrial dysfunction in neurodegenerative disorders. Neurotherapeutics21 (1), e00292. 10.1016/j.neurot.2023.10.002
61
KnezevicE.NenicK.MilanovicV.KnezevicN. N. (2023). The role of cortisol in chronic stress, neurodegenerative diseases, and psychological disorders. Cells12 (23), 2726. 10.3390/cells12232726
62
KnuppertzL.WarnsmannV.HamannA.GrimmC.OsiewaczH. D. (2017). Stress-dependent opposing roles for mitophagy in aging of the ascomycete Podospora anserina. Autophagy13 (6), 1037–1052. 10.1080/15548627.2017.1303021
63
KokkinopoulouI.MoutsatsouP. (2021). Mitochondrial glucocorticoid receptors and their actions. Int. J. Mol. Sci.22 (11), 6054. 10.3390/ijms22116054
64
KovachevaE.GevezovaM.MehterovN.KazakovaM.SarafianV. (2025). The intersection of mitophagy and autism spectrum disorder: a systematic review. Int. J. Mol. Sci.26 (5), 2217. 10.3390/ijms26052217
65
KwonO. C.SongJ. J.YangY.KimS. H.KimJ. Y.SeokM. J.et al (2021). SGK1 inhibition in glia ameliorates pathologies and symptoms in Parkinson disease animal models. EMBO Mol. Med.13 (4), e13076. 10.15252/emmm.202013076
66
LeeH.ChoS.KimM. J.ParkY. J.ChoE.JoY. S.et al (2023). ApoE4-dependent lysosomal cholesterol accumulation impairs mitochondrial homeostasis and oxidative phosphorylation in human astrocytes. Cell Rep.42 (10), 113183. 10.1016/j.celrep.2023.113183
67
LeemanD. S.HebestreitK.RuetzT.WebbA. E.McKayA.PollinaE. A.et al (2018). Lysosome activation clears aggregates and enhances quiescent neural stem cell activation during aging. Science359 (6381), 1277–1283. 10.1126/science.aag3048
68
LevyM. A.RelatorR.McConkeyH.PranckevicieneE.KerkhofJ.Barat-HouariM.et al (2022). Functional correlation of genome-wide DNA methylation profiles in genetic neurodevelopmental disorders. Hum. Mutat.43 (11), 1609–1628. 10.1002/humu.24446
69
LiX.ZhangJ.LiD.HeC.HeK.XueT.et al (2021). Astrocytic ApoE reprograms neuronal cholesterol metabolism and histone-acetylation-mediated memory. Neuron109 (6), 957–970.e958. 10.1016/j.neuron.2021.01.005
70
LiA.GaoM.LiuB.QinY.chenL.LiuH.et al (2022). Mitochondrial autophagy: molecular mechanisms and implications for cardiovascular disease. Cell Death and Dis.13 (5), 444. 10.1038/s41419-022-04906-6
71
LiJ.LaiM.ZhangX.LiZ.YangD.ZhaoM.et al (2022). PINK1-parkin-mediated neuronal mitophagy deficiency in prion disease. Cell Death Dis.13 (2), 162. 10.1038/s41419-022-04613-2
72
LiJ.YangD.LiZ.ZhaoM.WangD.SunZ.et al (2023). PINK1/Parkin-mediated mitophagy in neurodegenerative diseases. Ageing Res. Rev.84, 101817. 10.1016/j.arr.2022.101817
73
LiJ.ZhangZ.BoH.ZhangY. (2024). Exercise couples mitochondrial function with skeletal muscle fiber type via ROS-mediated epigenetic modification. Free Radic. Biol. Med.213, 409–425. 10.1016/j.freeradbiomed.2024.01.036
74
LiJ.BaiR.ZhouY.SongX.LiL. (2025). A mitochondria-to-nucleus regulation mediated by the nuclear-translocated mitochondrial lncRNAs. PLoS Genet.21 (1), e1011580. 10.1371/journal.pgen.1011580
75
LinJ.EpelE. (2022). Stress and telomere shortening: insights from cellular mechanisms. Ageing Res. Rev.73, 101507. 10.1016/j.arr.2021.101507
76
LinQ.LiS.JiangN.JinH.ShaoX.ZhuX.et al (2021). Inhibiting NLRP3 inflammasome attenuates apoptosis in contrast-induced acute kidney injury through the upregulation of HIF1A and BNIP3-mediated mitophagy. Autophagy17 (10), 2975–2990. 10.1080/15548627.2020.1848971
77
LiuH.HoP. W.LeungC. T.PangS. Y.ChangE. E. S.ChoiZ. Y.et al (2021). Aberrant mitochondrial morphology and function associated with impaired mitophagy and DNM1L-MAPK/ERK signaling are found in aged mutant Parkinsonian LRRK2(R1441G) mice. Autophagy17 (10), 3196–3220. 10.1080/15548627.2020.1850008
78
LiuQ.ZhaoJ. N.FangZ. T.WangX.ZhangB. G.HeY.et al (2024). BGP-15 alleviates LPS-induced depression-like behavior by promoting mitophagy. Brain Behav. Immun.119, 648–664. 10.1016/j.bbi.2024.04.036
79
LiuY.FlamierA.BellG. W.DiaoA. J.WhitfieldT. W.WangH. C.et al (2024). MECP2 directly interacts with RNA polymerase II to modulate transcription in human neurons. Neuron112 (12), 1943–1958.e1910. 10.1016/j.neuron.2024.04.007
80
LizamaB. N.ChuC. T. (2021). Neuronal autophagy and mitophagy in Parkinson’s disease. Mol. Asp. Med.82, 100972. 10.1016/j.mam.2021.100972
81
LouG.PalikarasK.LautrupS.Scheibye-KnudsenM.TavernarakisN.FangE. F. (2020). Mitophagy and neuroprotection. Trends Mol. Med.26 (1), 8–20. 10.1016/j.molmed.2019.07.002
82
LuG. L.ZouY. Q.LinM. Y.ChenH. L.ShuN. N.ChenL. Q.et al (2025). Wnt5a-AS knockdown alleviates sevoflurane-induced depression by promoting hippocampal neurogenesis and mitochondrial fusion in adolescent rats. Eur. J. Pharmacol.1003, 177931. 10.1016/j.ejphar.2025.177931
83
MaccariS.Morley-FletcherS. (2007). Effects of prenatal restraint stress on the hypothalamus-pituitary-adrenal axis and related behavioural and neurobiological alterations. Psychoneuroendocrinology32 (Suppl. 1), S10–S15. 10.1016/j.psyneuen.2007.06.005
84
MadoreC.YinZ.LeibowitzJ.ButovskyO. (2020). Microglia, lifestyle stress, and neurodegeneration. Immunity52 (2), 222–240. 10.1016/j.immuni.2019.12.003
85
MaerckerA.CloitreM.BachemR.SchlumpfY. R.KhouryB.HitchcockC.et al (2022). Complex post-traumatic stress disorder. Lancet400 (10345), 60–72. 10.1016/s0140-6736(22)00821-2
86
ManoliI.AlesciS.BlackmanM. R.SuY. A.RennertO. M.ChrousosG. P. (2007). Mitochondria as key components of the stress response. Trends Endocrinol. Metab.18 (5), 190–198. 10.1016/j.tem.2007.04.004
87
Marques-FeixaL.Palma-GudielH.RomeroS.Moya-HiguerasJ.Rapado-CastroM.Castro-QuintasÁ.et al (2023). Childhood maltreatment disrupts HPA-axis activity under basal and stress conditions in a dose-response relationship in children and adolescents. Psychol. Med.53 (3), 1060–1073. 10.1017/s003329172100249x
88
MartinezA.LectezB.RamirezJ.PoppO.SutherlandJ. D.UrbéS.et al (2017). Quantitative proteomic analysis of Parkin substrates in Drosophila neurons. Mol. Neurodegener.12 (1), 29. 10.1186/s13024-017-0170-3
89
McEwenB. S.NascaC.GrayJ. D. (2016). Stress effects on neuronal structure: hippocampus, Amygdala, and prefrontal cortex. Neuropsychopharmacology41 (1), 3–23. 10.1038/npp.2015.171
90
McWilliamsT. G.PrescottA. R.Montava-GarrigaL.BallG.SinghF.BariniE.et al (2018). Basal mitophagy occurs independently of PINK1 in mouse tissues of high metabolic demand. Cell Metab.27 (2), 439–449.e435. 10.1016/j.cmet.2017.12.008
91
MeuwissenM.VerstraetenA.RanzaE.IwaszkiewiczJ.BastiaansenM.MateiuL.et al (2022). Heterozygous variants in CTR9, which encodes a major component of the PAF1 complex, are associated with a neurodevelopmental disorder. Genet. Med.24 (7), 1583–1591. 10.1016/j.gim.2022.04.003
92
MiyamotoK.IshikuraK. I.KumeK.OhsawaM. (2019). Astrocyte-neuron lactate shuttle sensitizes nociceptive transmission in the spinal cord. Glia67 (1), 27–36. 10.1002/glia.23474
93
Mostafavi AbdolmalekyH.ZhouJ. R. (2024). Gut Microbiota dysbiosis, oxidative stress, inflammation, and epigenetic alterations in metabolic diseases. Antioxidants (Basel)13 (8), 985. 10.3390/antiox13080985
94
MuntsantA.Giménez-LlortL. (2022). Crosstalk of Alzheimer’s disease-phenotype, HPA axis, splenic oxidative stress and frailty in late-stages of dementia, with special concerns on the effects of social isolation: a translational neuroscience approach. Front. Aging Neurosci.14, 969381. 10.3389/fnagi.2022.969381
95
MuralidharanC.Zakar-PolyákE.AdamiA.AbbasA. A.SharmaY.GarzaR.et al (2025). Human brain cell-type-specific aging clocks based on single-nuclei transcriptomics. Adv. Sci. (Weinh)12 (43), e06109. 10.1002/advs.202506109
96
NapoliE.SongG.PanoutsopoulosA.RiyadhM. A.KaushikG.HalmaiJ.et al (2018). Beyond autophagy: a novel role for autism-linked Wdfy3 in brain mitophagy. Sci. Rep.8 (1), 11348. 10.1038/s41598-018-29421-7
97
NapoliE.PanoutsopoulosA. A.KysarP.SatriyaN.SterlingK.ShibataB.et al (2021). Wdfy3 regulates glycophagy, mitophagy, and synaptic plasticity. J. Cereb. Blood Flow. Metab.41 (12), 3213–3231. 10.1177/0271678x211027384
98
NarendraD. P.JinS. M.TanakaA.SuenD. F.GautierC. A.ShenJ.et al (2010). PINK1 is selectively stabilized on impaired mitochondria to activate Parkin. PLoS Biol.8 (1), e1000298. 10.1371/journal.pbio.1000298
99
NelsonN.BroadieK. (2025). Neuron-to-glia signaling drives critical period experience-dependent synapse pruning. Sci. Rep.15 (1), 25744. 10.1038/s41598-025-11528-3
100
NguyenT. N.Sawa-MakarskaJ.KhuuG.LamW. K.AdriaenssensE.FracchiollaD.et al (2023). Unconventional initiation of PINK1/Parkin mitophagy by Optineurin. Mol. Cell83 (10), 1693–1709.e1699. 10.1016/j.molcel.2023.04.021
101
NikkheslatN.McLaughlinA. P.HastingsC.ZajkowskaZ.NettisM. A.MarianiN.et al (2020). Childhood trauma, HPA axis activity and antidepressant response in patients with depression. Brain Behav. Immun.87, 229–237. 10.1016/j.bbi.2019.11.024
102
O’ConnorD. B.ThayerJ. F.VedharaK. (2021). Stress and health: a review of psychobiological processes. Annu. Rev. Psychol.72, 663–688. 10.1146/annurev-psych-062520-122331
103
PanigrahiD. P.PraharajP. P.BholC. S.MahapatraK. K.PatraS.BeheraB. P.et al (2020). The emerging, multifaceted role of mitophagy in cancer and cancer therapeutics. Semin. Cancer Biol.66, 45–58. 10.1016/j.semcancer.2019.07.015
104
PaolicelliR. C.BolascoG.PaganiF.MaggiL.ScianniM.PanzanelliP.et al (2011). Synaptic pruning by Microglia is necessary for normal brain development. Science333, 1456–1458. 10.1126/science.1202529
105
PiccaA.FaitgJ.AuwerxJ.FerrucciL.D’AmicoD. (2023). Mitophagy in human health, ageing and disease. Nat. Metab.5 (12), 2047–2061. 10.1038/s42255-023-00930-8
106
RedmannM.Darley-UsmarV.ZhangJ. (2016). The role of autophagy, mitophagy and lysosomal functions in modulating bioenergetics and survival in the context of redox and proteotoxic damage: implications for neurodegenerative diseases. Aging Dis.7 (2), 150–162. 10.14336/ad.2015.0820
107
SanacoraG.YanZ.PopoliM. (2022). The stressed synapse 2.0: pathophysiological mechanisms in stress-related neuropsychiatric disorders. Nat. Rev. Neurosci.23 (2), 86–103. 10.1038/s41583-021-00540-x
108
Sanguino-GómezJ.KrugersH. J. (2024). Early-life stress impairs acquisition and retrieval of fear memories: sex-effects, corticosterone modulation, and partial prevention by targeting glucocorticoid receptors at adolescent age. Neurobiol. Stress31, 100636. 10.1016/j.ynstr.2024.100636
109
SongY.CaoH.ZuoC.GuZ.HuangY.MiaoJ.et al (2023). Mitochondrial dysfunction: a fatal blow in depression. Biomed. Pharmacother.167, 115652. 10.1016/j.biopha.2023.115652
110
SotoJ. S.Jami-AlahmadiY.ChaconJ.MoyeS. L.Diaz-CastroB.WohlschlegelJ. A.et al (2023). Astrocyte-neuron subproteomes and obsessive-compulsive disorder mechanisms. Nature616 (7958), 764–773. 10.1038/s41586-023-05927-7
111
StavoeA. K. H.HolzbaurE. L. F. (2019). Autophagy in neurons. Annu. Rev. Cell Dev. Biol.35, 477–500. 10.1146/annurev-cellbio-100818-125242
112
StoccoroA.CoppedèF. (2021). Mitochondrial DNA methylation and human diseases. Int. J. Mol. Sci.22 (9), 4594. 10.3390/ijms22094594
113
SuL.ZhangJ.GomezH.KellumJ. A.PengZ. (2023). Mitochondria ROS and mitophagy in acute kidney injury. Autophagy19 (2), 401–414. 10.1080/15548627.2022.2084862
114
SunY.MuG.ZhangX.WuY.WangS.WangX.et al (2024). Metabolic modulation of histone acetylation mediated by HMGCL activates the FOXM1/β-catenin pathway in glioblastoma. Neuro Oncol.26 (4), 653–669. 10.1093/neuonc/noad232
115
SwerdlowN. S.WilkinsH. M. (2020). Mitophagy and the brain. Int. J. Mol. Sci.21 (24), 9661. 10.3390/ijms21249661
116
TanJ. X.FinkelT. (2023). Lysosomes in senescence and aging. EMBO Rep.24 (11), e57265. 10.15252/embr.202357265
117
ThangarajA.PeriyasamyP.GuoM. L.ChiveroE. T.CallenS.BuchS. (2020). Mitigation of cocaine-mediated mitochondrial damage, defective mitophagy and microglial activation by superoxide dismutase mimetics. Autophagy16 (2), 289–312. 10.1080/15548627.2019.1607686
118
Van den BerghB. R. H.van den HeuvelM. I.LahtiM.BraekenM.de RooijS. R.EntringerS.et al (2020). Prenatal developmental origins of behavior and mental health: the influence of maternal stress in pregnancy. Neurosci. Biobehav Rev.117, 26–64. 10.1016/j.neubiorev.2017.07.003
119
VermaM.LizamaB. N.ChuC. T. (2022). Excitotoxicity, calcium and mitochondria: a triad in synaptic neurodegeneration. Transl Neurodegener11 (1), 3. 10.1186/s40035-021-00278-7
120
VermaM.CallioJ.OteroP. A.SeklerI.WillsZ. P.ChuC. T. (2017). Mitochondrial calcium dysregulation contributes to dendrite degeneration mediated by PD/LBD-associated LRRK2 mutants. J. Neurosci.37 (46), 11151–11165. 10.1523/jneurosci.3791-16.2017
121
ViviE.Di BenedettoB. (2024). Brain stars take the lead during critical periods of early postnatal brain development: relevance of astrocytes in health and mental disorders. Mol. Psychiatry29 (9), 2821–2833. 10.1038/s41380-024-02534-4
122
ViviE.SeeholzerL. R.NagumanovaA.Di BenedettoB. (2023). Early Age- and sex-dependent regulation of Astrocyte-mediated glutamatergic synapse elimination in the rat prefrontal cortex: establishing an organotypic brain slice culture investigating tool. Cells12 (23), 2761. 10.3390/cells12232761
123
VizioliM. G.LiuT.MillerK. N.RobertsonN. A.GilroyK.LagnadoA. B.et al (2020). Mitochondria-to-nucleus retrograde signaling drives formation of cytoplasmic chromatin and inflammation in senescence. Genes Dev.34 (5-6), 428–445. 10.1101/gad.331272.119
124
WangZ.WhiteA.WangX.KoJ.ChoudharyG.LangeT.et al (2020). Mitochondrial fission mediated cigarette smoke-induced pulmonary endothelial injury. Am. J. Respir. Cell Mol. Biol.63 (5), 637–651. 10.1165/rcmb.2020-0008OC
125
WangT.ChenB.LuoM.XieL.LuM.LuX.et al (2023). Microbiota-indole 3-propionic acid-brain axis mediates abnormal synaptic pruning of hippocampal microglia and susceptibility to ASD in IUGR offspring. Microbiome11 (1), 245. 10.1186/s40168-023-01656-1
126
WangX.SunZ.YangT.LinF.YeS.YanJ.et al (2023). Sodium butyrate facilitates CRHR2 expression to alleviate HPA axis hyperactivity in autism-like rats induced by prenatal lipopolysaccharides through histone deacetylase inhibition. mSystems8 (4), e0041523. 10.1128/msystems.00415-23
127
WangH.YeJ.PengY.MaW.ChenH.SunH.et al (2024). CKLF induces microglial activation via triggering defective mitophagy and mitochondrial dysfunction. Autophagy20 (3), 590–613. 10.1080/15548627.2023.2276639
128
WangR.SunH.CaoY.ZhangZ.ChenY.WangX.et al (2024). Glucosylceramide accumulation in microglia triggers STING-dependent neuroinflammation and neurodegeneration in mice. Sci. Signal17 (829), eadk8249. 10.1126/scisignal.adk8249
129
WangJ.GaoY.ChenQ.XiongX.MiaoS.ChenX.et al (2026). Microglia mitochondrial metabolism in neurological diseases. Mol. Neurobiol.63 (1), 337. 10.1007/s12035-025-05640-8
130
WenF.GaoJ.ZhangG.GuoS.ZhangX.HanS.et al (2025). ROS-DRP1-mediated excessive mitochondrial fission and autophagic flux inhibition contribute to heat stress-induced apoptosis in goat Sertoli cells. J. Anim. Sci. Biotechnol.16 (1), 58. 10.1186/s40104-025-01180-2
131
WestA. P.Khoury-HanoldW.StaronM.TalM. C.PinedaC. M.LangS. M.et al (2015). Mitochondrial DNA stress primes the antiviral innate immune response. Nature520 (7548), 553–557. 10.1038/nature14156
132
WuX.ZhengY.LiuM.LiY.MaS.TangW.et al (2021). BNIP3L/NIX degradation leads to mitophagy deficiency in ischemic brains. Autophagy17 (8), 1934–1946. 10.1080/15548627.2020.1802089
133
XieC.ZhuangX. X.NiuZ.AiR.LautrupS.ZhengS.et al (2022). Amelioration of Alzheimer’s disease pathology by mitophagy inducers identified via machine learning and a cross-species workflow. Nat. Biomed. Eng.6 (1), 76–93. 10.1038/s41551-021-00819-5
134
XuX.PangY.FanX. (2025). Mitochondria in oxidative stress, inflammation and aging: from mechanisms to therapeutic advances. Signal Transduct. Target Ther.10 (1), 190. 10.1038/s41392-025-02253-4
135
XuY.WangQ.WangJ.QianC.WangY.LuS.et al (2025). The cGAS-STING pathway activates transcription factor TFEB to stimulate lysosome biogenesis and pathogen clearance. Immunity58 (2), 309–325.e306. 10.1016/j.immuni.2024.11.017
136
YamashitaA. S.da Costa RosaM.BorodovskyA.FestucciaW. T.ChanT.RigginsG. J. (2019). Demethylation and epigenetic modification with 5-azacytidine reduces IDH1 mutant glioma growth in combination with temozolomide. Neuro Oncol.21 (2), 189–200. 10.1093/neuonc/noy146
137
YanM.WangJ.WangH.ZhouJ.QiH.NajiY.et al (2023). Knockdown of NR3C1 inhibits the proliferation and migration of clear cell renal cell carcinoma through activating endoplasmic reticulum stress-mitophagy. J. Transl. Med.21 (1), 701. 10.1186/s12967-023-04560-2
138
YangF.WangX.QiJ.ZhangK.JiangY.FengB.et al (2022). Glucagon-like peptide 1 receptor activation inhibits microglial pyroptosis via promoting mitophagy to alleviate depression-like behaviors in diabetic mice. Nutrients15 (1), 38. 10.3390/nu15010038
139
YangL.AoY.LiY.DaiB.LiJ.DuanW.et al (2023). Morinda officinalis oligosaccharides mitigate depression-like behaviors in hypertension rats by regulating Mfn2-mediated mitophagy. J. Neuroinflammation20 (1), 31. 10.1186/s12974-023-02715-y
140
YangY.LiX.LiuF.MaM.YangY.RuanC.et al (2025). Immunometabolite L-2-HG promotes epigenetic modification of exhausted T cells and improves antitumor immunity. JCI Insight10 (7), e174600. 10.1172/jci.insight.174600
141
YiL.ShangX. J.LvL.WangY.ZhangJ.QuanC.et al (2022). Cadmium-induced apoptosis of Leydig cells is mediated by excessive mitochondrial fission and inhibition of mitophagy. Cell Death Dis.13 (11), 928. 10.1038/s41419-022-05364-w
142
YuanB.XiangX.YangT.LinF.YanJ.TongB.et al (2026). Prenatally elevated glucocorticoid disrupts social behavior via GR-Id3/E47-dependent astroglial dysfunction in LPS-induced autism-like rats. Biochem. Pharmacol.247, 117784. 10.1016/j.bcp.2026.117784
143
ZhangL.DaiL.LiD. (2021). Mitophagy in neurological disorders. J. Neuroinflammation18 (1), 297. 10.1186/s12974-021-02334-5
144
ZhangY.ZhangY.LeiY.WuJ.KangY.ZhengS.et al (2023). MDM2 upregulation induces mitophagy deficiency via Mic60 ubiquitination in fetal microglial inflammation and consequently neuronal DNA damage caused by exposure to ZnO-NPs during pregnancy. J. Hazard Mater457, 131750. 10.1016/j.jhazmat.2023.131750
145
ZhangF.ZhangL.HuG.ChenX.LiuH.LiC.et al (2024). Rectifying METTL4-Mediated N(6)-Methyladenine excess in mitochondrial DNA alleviates heart failure. Circulation150 (18), 1441–1458. 10.1161/circulationaha.123.068358
146
ZhangL.XieF.WangX.SunZ.HuH.WuY.et al (2024). N6-methyldeoxyadenosine modification difference contributes to homocysteine-induced mitochondrial perturbation in rat hippocampal primary neurons and PC12 cells. Biochem. Pharmacol.226, 116410. 10.1016/j.bcp.2024.116410
147
ZhangZ.YangW.WangL.ZhuC.CuiS.WangT.et al (2024). Unraveling the role and mechanism of mitochondria in postoperative cognitive dysfunction: a narrative review. J. Neuroinflammation21 (1), 293. 10.1186/s12974-024-03285-3
148
ZhangC.SunS.LeiL. M.JiangT. T.MaoH. Y.ChenC.et al (2025). Bisphenol AF exposure induced synaptic plasticity and neurobehavioral impairments via triggering the ROS-mediated PERK-eIF2α-ATF4 signaling pathway in adolescent mice. Ecotoxicol. Environ. Saf.303, 118846. 10.1016/j.ecoenv.2025.118846
149
ZhangL.XieF.WangX.SunZ.WuY.SunZ.et al (2025). Homocysteine induced N6-methyldeoxyadenosine modification perturbation elicits mitochondria dysfunction contributes to the impairment of learning and memory ability caused by early life stress in rats. Redox Biol.84, 103668. 10.1016/j.redox.2025.103668
150
ZhangZ.HuangS.WangY.JiangZ.LiuZ.WangC.et al (2026). Flipping the switch: MeCP2-Mediated lactylation rewires microglial metabolism and inflammation via the HK2/mTOR axis in poststroke neuroinflammation. Adv. Sci. (Weinh)13 (12), e13400. 10.1002/advs.202513400
151
ZhaoP.ShiW.YeY.XuK.HuJ.ChaoH.et al (2024). Atox1 protects hippocampal neurons after traumatic brain injury via DJ-1 mediated anti-oxidative stress and mitophagy. Redox Biol.72, 103156. 10.1016/j.redox.2024.103156
152
ZhengL.ShuW. J.LiY. M.MariM.YanC.WangD.et al (2020). The Paf1 complex transcriptionally regulates the mitochondrial-anchored protein Atg32 leading to activation of mitophagy. Autophagy16 (8), 1366–1379. 10.1080/15548627.2019.1668228
153
ZhongW.RaoZ.XuJ.SunY.HuH.WangP.et al (2022). Defective mitophagy in aged macrophages promotes mitochondrial DNA cytosolic leakage to activate STING signaling during liver sterile inflammation. Aging Cell21 (6), e13622. 10.1111/acel.13622
154
ZhouX.WangJ.YuL.QiaoG.QinD.Yuen-Kwan LawB.et al (2024). Mitophagy and cGAS-STING crosstalk in neuroinflammation. Acta Pharm. Sin. B14 (8), 3327–3361. 10.1016/j.apsb.2024.05.012
155
ZhouJ.LiuY.JingX.PengH.LiF.CaoL.et al (2026). MeCP2 dysregulation inhibits mitophagy and impairs neural development in cortical organoids. J. Adv. Res.82, 429–448. 10.1016/j.jare.2025.07.035
156
ZhuH. L.ShiX. T.XuX. F.ZhouG. X.XiongY. W.YiS. J.et al (2021). Melatonin protects against environmental stress-induced fetal growth restriction via suppressing ROS-mediated GCN2/ATF4/BNIP3-dependent mitophagy in placental trophoblasts. Redox Biol.40, 101854. 10.1016/j.redox.2021.101854
157
ZhuravlevaV.Vaz-SilvaJ.ZhuM.GomesP.SilvaJ. M.SousaN.et al (2021). Rab35 and glucocorticoids regulate APP and BACE1 trafficking to modulate Aβ production. Cell Death Dis.12 (12), 1137. 10.1038/s41419-021-04433-w
Summary
Keywords
CNS, epigenetic reprogramming, lifespan, mitophagy, psychological stress
Citation
Wang M, Zhang Z, Sha Z, Zhang F and Bao K (2026) The embedding of stress: mitophagy as a mechanism for the central nervous system (CNS) programming and lifelong disease vulnerability. Front. Cell Dev. Biol. 14:1808059. doi: 10.3389/fcell.2026.1808059
Received
10 February 2026
Revised
20 June 2026
Accepted
23 June 2026
Published
15 July 2026
Volume
14 - 2026
Edited by
Michael Schubert, UMR7009 Laboratoire de Biologie du Développement de Villefranche sur Mer, France
Reviewed by
Yinchuan Li, Nantong University, China
Sugato Banerjee, National Institute of Pharmaceutical Education and Research, India
Updates
Copyright
© 2026 Wang, Zhang, Sha, Zhang and Bao.
This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Kaifan Bao, bkf0824@njucm.edu.cn
† Present address: Meiling Wang, School of Immunology, Nanjing University of Chinese Medicine, Nanjing, China
Disclaimer
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.